Cardiac myosin activation: Will theory and practice coincide?

The Lancet

Volumn 378, Issue 9792, 2011, Pages 639-641

  Dickstein, Kenneth ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN; OMECAMTIV MECARBIL;

ACUTE HEART FAILURE; CALCIUM CELL LEVEL; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTOLE;

EID: 80051956025     PISSN: 0140-6736     EISSN: 1474-547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61298-1     Document Type: Note

References (12)

1. JR Teerlink, CP Clarke, KG Saikali et al. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study Lancet 378 2011 667 675
2. JGF Cleland, JR Teerlink, R Senior et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Lancet 378 2011 676 683
3. G Hasenfuss, JR Teerlink Cardiac inotropes: current agents and future directions Eur Heart J 32 2011 1838 1845
4. MS Cuffe, RM Califf, KF Adams Jr et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547 (Pubitemid 34269999)
5. FI Malik, JJ Hartman, KA Elias et al. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure Science 331 2011 1439 1443
6. YT Shen, FI Malik, X Zhao et al. Improvement of cardiac function by a cardiac myosin activator in conscious dogs with systolic heart failure Circ Heart Fail 3 2010 522 527
7. JD Thomas, ZB Popovic Assessment of left ventricular function by cardiac ultrasound J Am Coll Cardiol 48 2006 2012 2025 (Pubitemid 44738435)
8. GM Felker, RL Benza, AB Chandler et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 2003 997 1003 (Pubitemid 36315544)
9. JJV McMurray Systolic heart failure N Engl J Med 362 2010 228 238
10. CM O'Connor, RC Starling, AF Hernandez et al. Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
11. MA Konstam, M Gheorghiade, JC Burnett Jr et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331 (Pubitemid 46513233)
12. K Dickstein, A Cohen-Solal, G Filippatos et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology Eur J Heart Fail 10 2008 933 989